Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric rheumatology

Evaluation & Treatment of Systemic Sclerosis-ILD in the New Decade

Thomas R. Collins  |  December 17, 2020

ACR Convergence panelists discussed how to monitor SSc-ILD patients for ILD severity & the brightening prospects for therapy.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2020ILDinterstitial lung disease (ILD)Systemic sclerosis

COVID-19 Perspectives Shared in ACR Convergence Opening Session

Thomas R. Collins  |  November 23, 2020

ACR CONVERGENCE 2020—Eric Rubin, MD, PhD, took over as editor in chief of the New England Journal of Medicine in September 2019, just a few months before COVID-19 began taking over the world. Since then, Dr. Rubin’s perspective on the pandemic has been unlike that of any other person: He has led reviews of a…

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2020COVID-19Ellen GravalleseEric Rubin

The New Guidance Subcommittee Gives ACR More Document Flexibility

Ruth Jessen Hickman, MD  |  November 12, 2020

The ACR publishes multiple types of documents to provide guidance for its members, but some potentially beneficial topics have not fit neatly into existing production pathways. To answer the need, the ACR has formed a Guidance Subcommittee to the Quality of Care (QOC) Committee. This will allow the ACR to adapt more nimbly, when appropriate,…

Filed under:Clinical Criteria/GuidelinesFrom the College Tagged with:Committee on Quality of CareGuidance Subcommittee

ACR President Ellen Gravallese, MD, Says Farewell

Ellen M. Gravallese, MD  |  November 12, 2020

To the Members of the American College of Rheumatology, I had the honor and privilege of becoming the ACR’s 83rd president during the annual meeting in Atlanta in November 2019. My aspirations for the year were ambitious, filled with hopes of leading the ACR and the field of rheumatology forward in many new and bold…

Filed under:President's Perspective Tagged with:ACR president

ACR Convergence 2020: COVID-19 Hyper-Inflammation in Kids

Jason Liebowitz, MD, FACR  |  November 9, 2020

ACR CONVERGENCE 2020—Among the many ways in which the COVID-19 pandemic has changed the face of modern medicine is the emergence of multisystem inflammatory syndrome in children (MIS-C), a rare but serious condition that shares many features of Kawasaki disease (KD). With this topic in mind, leading pediatric experts from around the world came together…

Filed under:ACR ConvergenceConditionsMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2020COVID-19Multisystem Inflammatory Syndrome in Children (MIS-C)

Rheum After 5: Polly Ferguson, MD, Is Perfecting Her Pottery Skills

Carol Patton  |  November 5, 2020

After a busy day in rheumatology, Polly Ferguson, MD, gets creative at a local arts center, making beautiful pottery pieces, a skill she has wanted to develop for nearly 30 years.

Filed under:AudioProfilesRheum After 5 Tagged with:Dr. Polly Fergusonhobby

Outpatient Medicine in the Post-COVID-19 Era of Telemedicine

Richard L. Allman, MD, MS, FACP, FACR  |  October 19, 2020

Our hospitals have had their finest hour in the care of acutely ill inpatients during the COVID-19 pandemic, including dealing with allocation decisions fairly and transparently, maximizing good outcomes and remaining cognizant of the enduring ethics of healthcare. The honorable traditions of self-effacing conduct and acceptance of some level of personal risk by healthcare professionals…

Filed under:EthicsSpeak Out RheumTechnology Tagged with:COVID-19Speak Out Rheumatologytelemedicine

Case Report: A 40-Year-Old Man with Vasculitic Neuropathy

Case Report: A 40-Year-Old Man with Vasculitic Neuropathy

Martin Garber, DO, & David Fivenson, MD  |  October 19, 2020

Ironically, chronic exposure to minocycline has also been associated with a variety of autoimmune syndromes, including drug-induced lupus, auto­immune hepatitis, serum sickness and vasculitis.1 Minocycline is associated with an 8.5-fold increased risk of drug-induced lupus.2 Minocycline and nitrofurantoin are implicated in 90% of cases of drug-induced autoimmune hepatitis.3 Minocycline-induced vasculitis is much less common and,…

Filed under:ConditionsVasculitis Tagged with:minocyclinepolyarteritis nodosavasculitic neuropathy

Advocating for Change: Q&A with Georgia State Rep. Kim Schofield

Kimberly Retzlaff  |  October 19, 2020

Rep. Kim Schofield’s path to the Georgia House of Representatives started with her lupus diagnosis 20 years ago.

Filed under:Legislation & Advocacy Tagged with:Legislation & AdvocacyLupusRepresentative Kim Schofield

ACR Convergence 2020: From Clinic to Capitol Hill Session Offers Insights into Advocacy, Regulatory Issues

Vanessa Caceres  |  October 2, 2020

Attendees at the ACR Convergence session will learn about key regulatory issues affecting rheumatology and how to add their voices to strengthen the ACR’s advocacy efforts.

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2020AdvocacyBlair SolowZachary Wallace

  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 95
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences